188 related articles for article (PubMed ID: 10405543)
1. Viability and drug sensitivity of M. leprae isolated from long-term WHO/MDT treated multibacillary leprosy patients.
Habtemariam H
Lepr Rev; 1999 Mar; 70(1):43-6. PubMed ID: 10405543
[No Abstract] [Full Text] [Related]
2. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
[TBL] [Abstract][Full Text] [Related]
3. Higher incidence of viable Mycobacterium leprae within the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy.
Shetty VP; Suchitra K; Uplekar MW; Antia NH
Lepr Rev; 1997 Jun; 68(2):131-8. PubMed ID: 9217352
[TBL] [Abstract][Full Text] [Related]
4. Relapses in multibacillary leprosy patients after multidrug therapy.
Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
[TBL] [Abstract][Full Text] [Related]
5. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
Shetty VP; Suchitra K; Uplekar MW; Antia NH
Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
[TBL] [Abstract][Full Text] [Related]
6. A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
Pattyn S; Grillone S
Lepr Rev; 2000 Mar; 71(1):43-6. PubMed ID: 10820986
[No Abstract] [Full Text] [Related]
7. Are 18 doses of WHO/MDT sufficient for multibacillary leprosy; results of a trial in Malawi.
Pönnighaus JM; Boerrigter G
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):1-7. PubMed ID: 7730703
[TBL] [Abstract][Full Text] [Related]
8. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
9. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
10. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
[TBL] [Abstract][Full Text] [Related]
11. The activity of rifabutin against Mycobacterium leprae in armadillos.
Dhople AM; Williams SL
Int J Antimicrob Agents; 1997 Jan; 9(3):169-73. PubMed ID: 9552713
[TBL] [Abstract][Full Text] [Related]
12. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):622. PubMed ID: 7868967
[No Abstract] [Full Text] [Related]
13. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
Kaur I; Dogra S; Kumar B; Radotra BD
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
[TBL] [Abstract][Full Text] [Related]
14. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
Gupta UD; Katoch K; Katoch VM
Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
[TBL] [Abstract][Full Text] [Related]
15. [Our role in sentinel surveillance for drug resistance in leprosy by global leprosy programme].
Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):287-91. PubMed ID: 21941835
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
[TBL] [Abstract][Full Text] [Related]
17. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Ganapati R; Revankar CR; Pai VV; Kingsley S
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
[No Abstract] [Full Text] [Related]
18. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
19. The chemotherapy of leprosy: an interpretive history.
Gelber RH; Grosset J
Lepr Rev; 2012 Sep; 83(3):221-40. PubMed ID: 23356023
[No Abstract] [Full Text] [Related]
20. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
Sreevatsa ; Girdhar BK; Desikan KV
Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
